Healthcare

Falling demand sees J&J scale back COVID-19 vaccine

Falling demand sees J&J scale back COVID-19 vaccine

Pharmaphorum, January 16, 2023

With demand for its COVID-19 vaccine decreasing, Johnson & Johnson (J&J) has begun scaling back production of the shots. In the past few months, the New Brunswick, New Jersey-based pharmaceutical company has terminated manufacturing agreements with companies that helped to produce the vaccine during the pandemic, including Catalent and Sanofi.

 

Covid lockdowns were not necessarily a ‘net negative’

Covid lockdowns were not necessarily a ‘net negative’

The Washington Post, January 8, 2023

This book on men has a vital message and a model to follow,” Mitch Daniels’s Jan. 4 op-ed on the recent reissuance of the book, “Men Without Work: America’s Invisible Crisis,” was thoughtful. But he violated his own message of considering various perspectives without declaring certainty in his main example regarding the Great Barrington Declaration signers. His conclusion that “the condemnation they incurred was profoundly anti-intellectual and anti-scientific” was defensible, but his declaration that pandemic lockdown policies were unequivocally a “net negative” was not, as it was implicitly predicated on how objectives are weighted.

Cherry-picking profitable patients: New research identifies unintended consequences for some Medicare patients

Cherry-picking profitable patients: New research identifies unintended consequences for some Medicare patients

Singapore Management University, January 6, 2023

A new research in the INFORMS journal Manufacturing & Service Operations Management finds that Medicare Advantage (MA), the largest healthcare capitation program in the U.S., unintentionally incentivises health plans to cherry-pick profitable patients from traditional Medicare (TM). The study, “Can Big Data Cure Risk Selection in Healthcare Capitation Program? A Game Theoretical Analysis,” shows that even if the current MA risk adjustment design became informationally perfect through increased availability of big data, incentives would continue to persist for risk selection, primarily because of the way the current risk adjustment model is designed. Co-author SMU Assistant Professor of Operations Management Zhaowei She said, “No generic risk adjustment algorithm can solve the strategic prediction problem in risk adjustment without explicitly taking into account the underlying mechanism in healthcare capitation programs.” The study calls for practitioners and policymakers to change their views of seeing risk adjustment as a pure statistical and machine learning problem and to look more comprehensively at the human impact.

Medicare Patients May Face Unintended Consequences From Profiting

Medicare Patients May Face Unintended Consequences From Profiting

Mirage News, January 5, 2023

New research in the INFORMS journal Manufacturing & Service Operations Management finds that Medicare Advantage (MA), the largest healthcare capitation program in the U.S., unintentionally incentivizes health plans to cherry-pick profitable patients from traditional Medicare (TM). “Capitation” is the annual fee paid to a healthcare practice by each participant in a health plan.

Media Contact

Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
[email protected]
443-757-3578

See all Categories